Skip to main content

Table 1 Sampled antiretroviral medicines from medicine distribution outlets and number of samples selected and tested for confirmatory testing

From: Quality of selected anti-retroviral medicines: Tanzania Mainland market as a case study

Product name Samples collected and screened Confirmatory test
Samples collected Samples screened and passed Samples Failed Samples eligible for confirmatory Samples selected and tested
Efavirenz 66 66 0 7 14
Nevirapine tablets 34 34 0 4 7
Lamivudine tablets 10 10 0 1 10
Zidovudine tablets 2 2 0 1 2
Tenofovir Disoproxil Fumarate tablets 5 5 0 1 5
Lamivudine/Zidovudine tablets 70 70 0 7 7
Abacavir Sulphate tablets 16 16 0 2 4
Lopinavir/Ritonavir tablets 18 12 7 9 9
Tenofovir Disoproxil Fumarate /Emtricitabine tablets 14 14 0 2 4
Tenofovir Disoproxil Fumarate /Lamivudine/Efavirenz tablets 29 29 0 3 6
Lamivudine/Zidovune/Nevirapine tablets 73 73 7 14 14
Lamivudine/Stavudine/Nevirapine tablets 66 59 0 10 10
Tenofovir Disoproxil Fumarate /Efavirenz/Emtricitabine tablets 27 27 0 3 8
Total 430 416 14 61 100